Group Leader

1999, Bachelor of Science, Microbiology and Immunology, McGill University, Canada

2004, Doctor of Philosophy, Medical and Molecular Genetics, University of Toronto, Canada

In 2018 Mill was awarded the British Society for Cell Biology Women in Cell Biology Early Career Medal.

In 2018 Mill identified a new therapeutic technique for primary ciliary dyskinesia (PCD).[11] She proposed that drugs which make dynein motor proteins functional could improve the quality of life of patients suffering from primary ciliary dyskinesia.[11][12] In October 2018 Mill chaired the first PCD awareness day.[13] She proposed that the Government of the United Kingdom introduced early genetic diagnosis of PCD for babies with no identified causes of neonatal respiratory distress.[14] She hopes that genome editing will be able to treat PCD.

Mill was awarded a Canadian Natural Sciences and Engineering Research Council (NSERC) postdoctoral research fellowship to join the Medical Research Council (MRC) Human Genetics Unit (HGU).

She worked at the Hospital for Sick Children and earned her PhD in 2004

MRC Human Genetics Unit at the University of Edinburgh

group leader

Mill completed her bachelor's degree at McGill University in 1999

McGill University, Montréal, Canada

the University of Toronto, Canada